» Articles » PMID: 37528333

Lysinuric Protein Intolerance Presenting As Pancytopenia and Splenomegaly Mimicking Acute Leukaemia: a Case Report

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2023 Aug 1
PMID 37528333
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lysinuric protein intolerance is a rare inherited metabolic disease due to autosomal recessive mutations of the SLC7A7 gene. The affected patients commonly present with protein-rich food intolerance, failure to thrive, hepatosplenomegaly, muscle hypotonia and lung involvement due to impaired intestinal absorption and excessive urinary excretion of dibasic amino acids. Presentation with splenomegaly and cytopenia without other features has not been reported. Here we report a Sri Lankan girl with lysinuric protein intolerance presenting with pancytopenia and splenomegaly mimicking acute leukaemia.

Case Presentation: Two years and six months old Sri Lankan girl presented with persistent pancytopenia following a viral illness. She was asymptomatic without vomiting, diarrhoea, abdominal pain or irritability. Physical examination revealed pallor and isolated firm splenomegaly of 2 cm. Growth parameters and other system examinations were normal. Full blood count revealed anaemia, leukopenia and thrombocytopenia. The blood picture showed a mixture of hypochromic microcytic and normochromic normocytic red cells with occasional pencil cells and macrocytes. Bone marrow examination was normal except for occasional megaloblasts; however, serum vitamin B12 and red blood cell folate were normal. The metabolic screen showed a high anion gap compensated metabolic acidosis, high lactate and ketosis. Genetic mutation analysis using whole exome sequencing revealed compound heterozygous variants of the SLC7A7 gene, confirming the diagnosis of lysinuric protein intolerance.

Conclusion: We report a child with lysinuric protein intolerance presenting with pancytopenia and splenomegaly without other disease features. This case report adds to the heterogenic presentations of lysinuric protein intolerance, which is considered a multifaceted disease.

Citing Articles

Blood cytopenias as manifestations of inherited metabolic diseases: a narrative review.

Moutapam-Ngamby-Adriaansen Y, Maillot F, Labarthe F, Lioger B Orphanet J Rare Dis. 2024; 19(1):65.

PMID: 38355710 PMC: 10865644. DOI: 10.1186/s13023-024-03074-4.

References
1.
Carpentieri D, Barnhart M, Aleck K, Miloh T, deMello D . Lysinuric protein intolerance in a family of Mexican ancestry with a novel SLC7A7 gene deletion. Case report and review of the literature. Mol Genet Metab Rep. 2017; 2:47-50. PMC: 5471162. DOI: 10.1016/j.ymgmr.2014.12.005. View

2.
Doireau V, Fenneteau O, Duval M, Perelman S, Vilmer E, Touati G . [Lysinuric dibasic protein intolerance: characteristic aspects of bone marrow involvement]. Arch Pediatr. 1996; 3(9):877-80. DOI: 10.1016/0929-693x(96)87577-4. View

3.
Riccio E, Pisani A . Fanconi syndrome with lysinuric protein intolerance. Clin Kidney J. 2015; 7(6):599-601. PMC: 4389143. DOI: 10.1093/ckj/sfu107. View

4.
Matthews D . Review of Lysine Metabolism with a Focus on Humans. J Nutr. 2020; 150(Suppl 1):2548S-2555S. DOI: 10.1093/jn/nxaa224. View

5.
Noguchi A, Takahashi T . Overview of symptoms and treatment for lysinuric protein intolerance. J Hum Genet. 2019; 64(9):849-858. DOI: 10.1038/s10038-019-0620-6. View